Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **VP2 protein** is a viral structural protein that forms part of the capsid in multiple virus families. In polyomaviruses, VP2 is a minor capsid protein located inside the viral shell and is essential for proper genome packaging and entry into host cells[1][5]. In IBDV, VP2 forms trimers that are key building blocks of the capsid, providing important immunogenic epitopes for neutralizing antibodies[2][4]. In BTV, VP2 is the principal determinant of serotype specificity and mediates attachment and penetration during infection, making it a major vaccine target[3]. In DWV, VP2 interacts with host proteins (e.g., snapin), potentially influencing viral assembly and neuropathogenesis[7]. Across viruses, VP2's surface loops display sequence variability, influencing immune recognition and epitope diversity[6][4][8]. Direct drug targeting of VP2 is uncommon, but its antigenic properties make it a focus for vaccine development and serological assays. If VP2 is referenced without specifying virus type, additional characterization should be provided, as VP2 is a conserved nomenclature for various unrelated viral proteins. Each VP2 fulfills parallel roles in viral structure and function, with some species-specific molecular and immunological features.
Neutralizing antibodies block viral entry by binding VP2 and preventing receptor interaction (e.g., BTV). VP2–host protein interactions influence virus assembly (e.g., snapin—DWV).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Viral protein 2 (VP2) (VP2).